Skip to main content

Meet the Analyst: Thomas Wakim & John Hester, Bell Potter Analyst

Bell Direct
December 17, 2024

Join us as we conclude our 2024 Meet the Analyst series with a bang. Our Market Analyst, Grady Wulff, sits down with Bell Potter’s analysts John Hester and Thomas Wakim for a comprehensive discussion on the healthcare sector.

From deciphering Neuren Pharmaceuticals (ASX:NEU) share price fluctuations to anticipating the news flow that will share 2025 guidance and identifying why Telix Pharmaceuticals (ASX:TLX) and Clarity Pharmaceuticals (ASX:CU6) are stocks to watch in the new year, John and Thomas cover it all in this final episode of the year.

In this video, John and Thomas discuss:

  • (1:48): the headwinds & tailwinds facing the healthcare sector
  • (7:10): why they are bullish on Neuren
  • (13:48): opportunities in healthcare stocks for 2025
  • (15:18): what’s on their clinical data radar for the upcoming year.

April Overview

Bell Direct
April 26, 2017

Market Update

Julia Lee
April 24, 2017

Market Update

Bell Direct
April 21, 2017

Market Update

Bell Direct
April 20, 2017

Market Update

Bell Direct
April 19, 2017

Market Update

Bell Direct
April 18, 2017

Market Update

Bell Direct
April 13, 2017

Market Update

Bell Direct
April 12, 2017

Market Update

Bell Direct
April 11, 2017

Market Update

Bell Direct
April 10, 2017

Market Update

Julia Lee
April 7, 2017

Market Update

Julia Lee
April 6, 2017